Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the misfolding of a specific protein, leading to its toxic accumulation in the form ... The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein called amyloid-β was responsible for memory loss in Alzheimer’s disease.
On its ... News Medical: Minimally invasive biopsy enables real-time tracking of amyloid disease progression Medical Xpress: Blood test can predict Alzheimer's disease progression years before symptoms or brain scan changes A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid PET ... Blood test can predict Alzheimer's disease progression years before symptoms or brain scan changes Healio: Improve access to amyloidosis care by recognizing ‘red flag’ symptoms, collaboration Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...
